UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

UBC - May 09, 2013
One week isn’t nearly enough time to recognize everything nurses do for us.  Let’s face it – nurses save lives.  Day in, day out, they provide care and education, administer medication, and evaluate patients’ symptoms....
, Executive Director & Principal Scientific Consultant, Value Demonstration - May 07, 2013
Traditionally, chart review studies have been employed to evaluate burden of illness and patterns of care, but, increasingly, this methodology is being applied to meet marketing authorization and risk management data requirements...
UBC - May 03, 2013
Traditional prescription adherence measures have been around for two to three decades.  These programs’ ability to drive patient compliance are well understood – both in their effectiveness and their limitations. Cost reduction...
UBC - April 29, 2013
When developing a European Risk Minimization program, one size really doesn’t fit all.  Manufacturers must consider that healthcare practices vary across Europe, leading to challenges in the implementation of risk minimization...
UBC - April 26, 2013
ISPOR, the International Society for Pharmacoeconomics and Outcomes Research, is recognized globally as the authority for health economics and outcomes research and its use in healthcare decisions towards improved health.  ...

Pages